Literature DB >> 14622899

Androgens modulate neuronal vulnerability to kainate lesion.

M Ramsden1, T M Shin, C J Pike.   

Abstract

Testosterone has been shown to have multiple beneficial effects on neuronal viability in developing and adult animals. Most often, testosterone promotes neural health indirectly via enzymatic conversion to estradiol by aromatase. Unclear is whether androgens can directly modulate vulnerability to neuronal insults in adult animals. We investigated this issue by modulating androgen status in rats prior to challenge with the excitotoxin kainate. Adult male rats were maintained in the following conditions: i) gonadectomized (GDX) to deplete endogenous androgens, ii) GDX+replacement with dihydrotestosterone (DHT) the active and non-aromatizable testosterone metabolite, iii) sham-GDX. Animals were then lesioned with kainate and surviving hippocampal neurons quantified. In the CA2/3 and hilar regions of the hippocampus, a modest lesion was observed in sham-GDX animals corresponding to approximately 25% cell loss in comparison to non-lesioned rats. The depletion of endogenous androgens by GDX significantly augmented lesion severity, consistent with the hypothesis that androgens are involved in maintaining cell viability. Importantly, DHT hormone replacement in GDX rats significantly attenuated kainate-induced neuron loss in CA2/3, suggesting direct androgen neuroprotection. These results demonstrate that androgens act as endogenous modulators of neuron viability, a function that may be compromised in aging men as a consequence of normal, age-related androgen depletion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622899     DOI: 10.1016/j.neuroscience.2003.08.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

Review 1.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Rapid seasonal-like regression of the adult avian song control system.

Authors:  Christopher K Thompson; George E Bentley; Eliot A Brenowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

Review 3.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

4.  Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats.

Authors:  Jenna C Carroll; Emily R Rosario; Christian J Pike
Journal:  Neurosci Lett       Date:  2008-09-07       Impact factor: 3.046

5.  Sex- and age-dependent effects of androgens on glutamate-induced cell death and intracellular calcium regulation in the developing hippocampus.

Authors:  S L Zup; N S Edwards; M M McCarthy
Journal:  Neuroscience       Date:  2014-09-28       Impact factor: 3.590

Review 6.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 7.  Seasonal-like growth and regression of the avian song control system: neural and behavioral plasticity in adult male Gambel's white-crowned sparrows.

Authors:  John Meitzen; Christopher K Thompson
Journal:  Gen Comp Endocrinol       Date:  2008-03-25       Impact factor: 2.822

8.  Neuroprotective effects of testosterone metabolites and dependency on receptor action on the morphology of somatic motoneurons following the death of neighboring motoneurons.

Authors:  Yi Cai; Cory Chew; Fernando Muñoz; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2016-10-03       Impact factor: 3.964

9.  Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta.

Authors:  Rebecca L Cunningham; Andrea Giuffrida; James L Roberts
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

10.  Progress update: Pharmacological treatment of Alzheimer's disease.

Authors:  David B Hogan
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.